SPOTLIGHT -
Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine Prophylactic
The professor of neurology at both the University of California San Francisco and King’s College, London, spoke about the results from a phase 2b/3 study evaluating atogepant for prevention of migraine.
Peter Goadbsy, MD, PhD, DSc: Differentiating Between CGRPs, Synthesizing the Gepants
Goadsby spoke about differentiating between the foursome of preventive therapies soon to be available to physicians.
